Regeneron Pharmaceuticals, Inc. (REGN)

748.87 -18.98 (-2.47%) USD  |  NASDAQ  |  Apr 10, 16:00
748.20 -0.67 (-0.09%) Pre-Market: 08:35
More

Regeneron Pharmaceuticals Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for REGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
AbbVie, Inc. Upgrade